These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30358932)

  • 1. Multiparametric MRI: an important tool to improve risk stratification for active surveillance in prostate cancer.
    Chandrasekar T; Dall'Era MA; Tilki D
    BJU Int; 2018 Nov; 122(5):721-722. PubMed ID: 30358932
    [No Abstract]   [Full Text] [Related]  

  • 2. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
    Recabal P; Assel M; Sjoberg DD; Lee D; Laudone VP; Touijer K; Eastham JA; Vargas HA; Coleman J; Ehdaie B
    J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When to Order an MRI in the Initial Evaluation and Management of Prostate Cancer.
    Walton-Diaz A; Rais-Bahrami S
    Oncology (Williston Park); 2018 Oct; 32(10):501-4. PubMed ID: 30334240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of multiparametric MRI into active surveillance of prostate cancer.
    Holtz JN; Tay KJ; Polascik TJ; Gupta RT
    Future Oncol; 2016 Nov; 12(21):2513-2529. PubMed ID: 27322161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric magnetic resonance imaging and prostate cancer: what's new?
    Catalá V; Vilanova JC; Gaya JM; Algaba F; Martí T
    Radiologia; 2017; 59(3):196-208. PubMed ID: 28236452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
    Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
    NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.
    Schulman AA; Sze C; Tsivian E; Gupta RT; Moul JW; Polascik TJ
    Curr Urol Rep; 2017 Jul; 18(7):52. PubMed ID: 28589398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer?
    Porpiglia F; Cantiello F; De Luca S; De Pascale A; Manfredi M; Mele F; Bollito E; Cirillo S; Damiano R; Russo F
    Int J Urol; 2016 Sep; 23(9):752-7. PubMed ID: 27277398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
    Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA
    Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Characteristics of Prostate Cancer Patients Who Discontinued Active Surveillance on 3-T Multiparametric Prostate MRI.
    Habibian DJ; Liu CC; Dao A; Kosinski KE; Katz AE
    AJR Am J Roentgenol; 2017 Mar; 208(3):564-569. PubMed ID: 28075651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.
    Salmasi A; Said J; Shindel AW; Khoshnoodi P; Felker ER; Sisk AE; Grogan T; McCullough D; Bennett J; Bailey H; Lawrence HJ; Elashoff DA; Marks LS; Raman SS; Febbo PG; Reiter RE
    J Urol; 2018 Sep; 200(3):564-572. PubMed ID: 29524506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric magnetic resonance imaging: Current role in prostate cancer management.
    Ueno Y; Tamada T; Bist V; Reinhold C; Miyake H; Tanaka U; Kitajima K; Sugimura K; Takahashi S
    Int J Urol; 2016 Jul; 23(7):550-7. PubMed ID: 27184019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
    BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MRI in active surveillance for men with localized prostate cancer.
    Recabal P; Ehdaie B
    Curr Opin Urol; 2015 Nov; 25(6):504-9. PubMed ID: 26372037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.
    Bryant RJ; Hobbs CP; Eyre KS; Davies LC; Sullivan ME; Shields W; Sooriakumaran P; Verrill CL; Gleeson FV; MacPherson RE; Hamdy FC; Brewster SF
    J Urol; 2019 Mar; 201(3):510-519. PubMed ID: 30266332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.
    Watson MJ; George AK; Maruf M; Frye TP; Muthigi A; Kongnyuy M; Valayil SG; Pinto PA
    Future Oncol; 2016 Nov; 12(21):2417-2430. PubMed ID: 27400645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MRI of the prostate].
    Nörenberg D; Solyanik O; Schlenker B; Magistro G; Ertl-Wagner B; Clevert DA; Stief C; Reiser MF; D'Anastasi M
    Urologe A; 2017 May; 56(5):665-677. PubMed ID: 28424829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System.
    Christidis D; McGrath S; Leaney B; O'Sullivan R; Lawrentschuk N
    Urology; 2018 Jan; 111():136-138. PubMed ID: 28823635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.